Medical abortion at home and at hospital: A trial of efficacy and acceptability

被引:5
作者
Provansal, M. [1 ]
Mimari, R. [1 ]
Gregoire, B. [1 ]
Agostini, A. [1 ]
Thirion, X. [2 ]
Gamerre, M. [1 ]
机构
[1] Hop Conception, Ctr Gynecol Sociale, F-13005 Marseille, France
[2] Fac Med Timone, EA 3279, Lab Sante Publ, F-13005 Marseille, France
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2009年 / 37卷 / 11-12期
关键词
Medical abortion; Mifepristone; Efficacy; Failure rates; Acceptability; EARLY-PREGNANCY; MIFEPRISTONE; MISOPROSTOL; TERMINATION; FAILURE; WOMEN;
D O I
10.1016/j.gyobfe.2009.07.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. - To evaluate the efficacy and the acceptability of medical abortion at home and at hospital. Patients and methods. - From 11 February 2008 to 16 July 2008, 399 patients were included in the study: 173 at home and 226 at hospital. Results. - Efficacy was evaluated for 305 patients because 94 were lost of follow-up (23.6%). Efficacy of medical abortion was 86.7% (124/143) at home and 95.8% (155/162) at hospital. There were one ongoing pregnancy and 25 surgical aspirations (8.6%). The family planning nurse received a phone call from five patients after mifepristone at home (2.9%) and seven patients after mifepristone at hospital (3.1%). Only one patient "at home" had an emergency consultation (0.6%) and nine patients "at hospital" (4%). Ten patients went back to their gynecologist before their appointment for follow-up (2.5%): five "at home" (2.9%) and five "at hospital" (2.2%). Thirteen patients were referred by the private provider to the hospital medical specialist. Acceptability is known for 70.2% of patients: 98% thought that medical abortion at home was acceptable and 92.9% at hospital. Discussion and conclusion. - The failure rate of medical abortion is higher at home and is due to aspirations for incomplete abortion. The procedure at home seems to be more acceptable than at hospital. It will be interesting to realize a prospective randomized study to compare the procedures at home and at hospital. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 18 条
[1]  
Beucher G, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P5
[2]   The medical abortion experiences of married and unmarried women in Tunis, Tunisia [J].
Blum, J ;
Hajri, S ;
Chélli, H ;
Ben Mansour, F ;
Gueddana, N ;
Winikoff, B .
CONTRACEPTION, 2004, 69 (01) :63-69
[3]   TERMINATION OF EARLY-PREGNANCY BY THE PROGESTERONE ANTAGONIST RU-486 (MIFEPRISTONE) [J].
COUZINET, B ;
LESTRAT, N ;
ULMANN, A ;
BAULIEU, EE ;
SCHAISON, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) :1565-1570
[4]  
Dagousset I, 2004, Gynecol Obstet Fertil, V32, P28, DOI 10.1016/j.gyobfe.2003.11.005
[5]  
Elul B, 2000, J Am Med Womens Assoc (1972), V55, P169
[6]  
Faucher P, 2005, Gynecol Obstet Fertil, V33, P220, DOI 10.1016/j.gyobfe.2005.02.021
[7]   Verifying the effectiveness of medical abortion; ultrasound versus hCG testing [J].
Fiala, C ;
Safar, P ;
Bygdeman, M ;
Gemzell-Danielsson, K .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 109 (02) :190-195
[8]   A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation [J].
Gallo, MF ;
Cahill, S ;
Castleman, L ;
Mitchell, EMH .
CONTRACEPTION, 2006, 74 (01) :36-41
[9]   Mifepristone-misoprostol medical abortion: Home administration of misoprostol in Guadeloupe [J].
Guengant, JP ;
Bangou, J ;
Elul, B ;
Ellertson, C .
CONTRACEPTION, 1999, 60 (03) :167-172
[10]   Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States [J].
Hausknecht, R .
CONTRACEPTION, 2003, 67 (06) :463-465